Krassimir Mitchev
Chief Tech/Sci/R&D Officer chez CALLIDITAS THERAPEUTICS AB
Profil
Krassimir Mitchev is currently the Director & Principal Owner at Arden Regulatory Clinical & Medical Consulting Ltd.
and the Head-Medical Affairs at Calliditas Therapeutics AB.
Previously, he worked as the Head-Medical Affairs at Calliditas Therapeutics AB in 2019 and as the Vice President at Swedish Orphan Biovitrum AB from 2013 to 2018.
He holds a doctorate degree from Medical University Sofia.
Postes actifs de Krassimir Mitchev
| Sociétés | Poste | Début |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Chief Tech/Sci/R&D Officer | 24/07/2020 |
| Arden Regulatory Clinical & Medical Consulting Ltd. | Director/Board Member | 01/07/2018 |
Anciens postes connus de Krassimir Mitchev
| Sociétés | Poste | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01/05/2018 |
| CALLIDITAS THERAPEUTICS AB | Chief Tech/Sci/R&D Officer | - |
Formation de Krassimir Mitchev
| Medical University Sofia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Arden Regulatory Clinical & Medical Consulting Ltd. |
